FDA Schedules Meeting on July 14, 2025, on Reauthorization of Prescription Drug User Fee Act
June 05, 2025
June 05, 2025
WASHINGTON, June 5 (TNSmeet) -- The Food and Drug Administration will conduct a public meeting on July 14, 2025, to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act for fiscal 2028 through 2032. This act authorizes the agency to collect user fees that support the review process for human drug applications. The current legislative authority for this program expires in September 2027, requiring new legislation for the organization to continue collectin . . .